sulforadex
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01948362)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sulforadex
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02055716 | Phase 1 | Jan 1, 2014 | Evgen Pharma, Richmond Pharmacology |
| NCT01948362 | Phase 1 | Nov 1, 2012 | Evgen Pharma, Richmond Pharmacology |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Evgen Pharma | For profit | 2 | 2 | 1 | 2012 |
| Richmond Pharmacology | For profit | 2 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1